510(k) Report

FDA applicant

Safecare Biotech (Hangzhou) Co., Ltd.

Hangzhou, CN9 decisions2016–20250 recalls

FDA records 9 decisions for Safecare Biotech (Hangzhou) Co., Ltd. (Hangzhou, CN) from 2016 to 2025: 9 510(k) clearances. Most are in product codes NFT (Test, Amphetamine, Over The Counter) and LCX (Kit, Test, Pregnancy, Hcg, Over The Counter). Since 2016 its 510(k)s took a median of 61 days from receipt to decision, against 72 for FDA’s reviews in the same codes and years. Its devices cite 9 predicates, 3 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Safecare Biotech (Hangzhou) Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2016: 12018: 22019: 12020: 22021: 12024: 12025: 1
2016high 2 (2018) · low 0 (2017)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2016.

FIG. 1 — Safecare Biotech (Hangzhou) Co., Ltd. by year, 2016–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Safecare Biotech (Hangzhou) Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report